The First Affiliated Hospital with Nanjing Medical University clinical trial pipeline

12 trials changed in the last 30 days: 0 stopped, 5 with notable changes, 7 with minor changes only.

1. Notable

   IPSCs-derived RPE Cells Transplantation for Advanced (Late-stage)…IPSCs-derived RPE Cells Transplantation for Advanced (Late-stage) AMD

   Primary completion pushed from Jun 1, 2028 to Dec 31, 2028

   Also in this update: Primary endpoint(s) modified; Recruitment opened

   The First Affiliated Hospital with Nanjing Medical University·Phase 1/2· NCT07418177· Registry history of NCT07418177 on ClinicalTrials.gov (opens the registry)

   Oct 19, 2026

2. Notable

   IAT-MEVO · Intra-arterial Thrombolysis For Acute Ischemic Stroke…IAT-MEVO · Intra-arterial Thrombolysis For Acute Ischemic Stroke With Medium Vessel Occlusion

   Primary completion pushed from Jul 30, 2028 to Jan 31, 2029

   Also in this update: Primary endpoint(s) modified; Recruitment opened

   The First Affiliated Hospital with Nanjing Medical University·Phase 3· NCT07668323· Registry history of NCT07668323 on ClinicalTrials.gov (opens the registry)

   Sep 23, 2026

3. Notable

   HRVPOD · Heart Rate Variability Changes and Postoperative…HRVPOD · Heart Rate Variability Changes and Postoperative Delirium After Major Abdominal Surgery

   Recruitment opened

   Also in this update: Start date changed from estimate of Sep 1, 2026 to Sep 21, 2026

   The First Affiliated Hospital with Nanjing Medical University·Not specified· NCT07783464· Registry history of NCT07783464 on ClinicalTrials.gov (opens the registry)

   Sep 28, 2026

4. Notable

   Breast Ultrasound Screening in Elderly Women: A Multicenter…Breast Ultrasound Screening in Elderly Women: A Multicenter Cluster Randomized Trial

   Recruitment opened

   Also in this update: Primary completion pushed from Jul 10, 2029 to Sep 20, 2029; Interventions modified

   The First Affiliated Hospital with Nanjing Medical University·Not applicable· NCT07698366· Registry history of NCT07698366 on ClinicalTrials.gov (opens the registry)

   Sep 28, 2026

5. Notable

   H-FROG · Perioperative Retlirafusp Alfa(Anti-PD-L1/TGF-β…H-FROG · Perioperative Retlirafusp Alfa(Anti-PD-L1/TGF-β Bifunctional Fusion Protein) Plus Famitinib and GEMOX-Based Hepatic Arterial Infusion Chemotherapy for Locally Advanced Intrahepatic Cholangiocarcinoma: A Multicenter, Single-Arm, Exploratory Phase II Trial

   Start date pushed from Aug 1, 2026 to Sep 30, 2026

   The First Affiliated Hospital with Nanjing Medical University·Phase 2· NCT07847710· Registry history of NCT07847710 on ClinicalTrials.gov (opens the registry)

   Oct 9, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.